Doctor Georg Gelbenegger
Medical University of Vienna, Vienna (Austria)
Aspirin for primary prevention of cardiovascular disease
Event: ESC Congress 2019
Topic: Cardiovascular Risk Assessment
Session: Atrial fibrillation, anti-platelet therapy, anticoagulation and bleeding
ESC 365 is supported by
